Literature DB >> 22364522

The regenerative potential of angiotensin AT2 receptor in cardiac repair.

Marion Ludwig1, Gustav Steinhoff, Jun Li.   

Abstract

Angiotensin II, the main effector peptide of the renin-angiotensin system, interferes with cardiac remodeling and repair through its receptors, including AT(1) and AT(2) receptor (R). The functional relevance of the previously neglected AT(2)R is currently intensively studied. Pharmacological therapies with AT(1)R blockers have improved outcomes in patients with ischemic heart injury, probably involving an indirect stimulation of AT(2)R. Previous experimental studies have clearly shown a protective action of AT(2)R in tissue repair and regeneration. We have recently identified the c-kit(+)AT(2)R(+) progenitor cell population in rat heart and bone marrow, which increases after induction of myocardial infarction. Further experimental evidence demonstrates that AT(2)R mediates cardiac homing and repair process of the c-kit(+) progenitor cells. AT(2)R stimulation through AT(1)R blockers or directly by AT(2)R agonist or both in combination may potentially offer the translational options to improve the regenerative potentials of stem/progenitor cells derived from patients with cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364522     DOI: 10.1139/y11-108

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  12 in total

1.  The birth of 'regenerative pharmacology': a clinical perspective.

Authors:  T R Choudhury; A Mathur
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

2.  Characterization of superoxide dismutases in cardiac progenitor cells demonstrates a critical role for manganese superoxide dismutase.

Authors:  Gokulakrishnan Seshadri; Pao Lin Che; Archana V Boopathy; Michael E Davis
Journal:  Stem Cells Dev       Date:  2012-08-01       Impact factor: 3.272

Review 3.  Targeting Angiotensin-Converting Enzyme-2/Angiotensin-(1-7)/Mas Receptor Axis in the Vascular Progenitor Cells for Cardiovascular Diseases.

Authors:  Yagna P R Jarajapu
Journal:  Mol Pharmacol       Date:  2020-04-22       Impact factor: 4.436

4.  Effects of sildenafil and/or muscle derived stem cells on myocardial infarction.

Authors:  Judy Sc Wang; Istvan Kovanecz; Dolores Vernet; Gaby Nolazco; George E Kopchok; Sheryl L Chow; Rodney A White; Nestor F Gonzalez-Cadavid
Journal:  J Transl Med       Date:  2012-08-07       Impact factor: 5.531

Review 5.  Endocrine Influence on Cardiac Metabolism in Development and Regeneration.

Authors:  Niall Graham; Guo N Huang
Journal:  Endocrinology       Date:  2021-09-01       Impact factor: 5.051

6.  Differential Effects of β-Blockers, Angiotensin II Receptor Blockers, and a Novel AT2R Agonist NP-6A4 on Stress Response of Nutrient-Starved Cardiovascular Cells.

Authors:  Abuzar Mahmood; Lakshmi Pulakat
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

7.  Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II.

Authors:  Francesca Magnani; Charalampos G Pappas; Tim Crook; Vassiliki Magafa; Paul Cordopatis; Susumu Ishiguro; Naomi Ohta; Jana Selent; Sanja Bosnyak; Emma S Jones; Ioannis P Gerothanassis; Masaaki Tamura; Robert E Widdop; Andreas G Tzakos
Journal:  ACS Chem Biol       Date:  2014-05-14       Impact factor: 5.100

8.  Human heart valve-derived scaffold improves cardiac repair in a murine model of myocardial infarction.

Authors:  Long Wan; Yao Chen; Zhenhua Wang; Weijun Wang; Sebastian Schmull; Jun Dong; Song Xue; Hans Imboden; Jun Li
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

9.  Cardiovascular disease progression in female Zucker Diabetic Fatty rats occurs via unique mechanisms compared to males.

Authors:  Kelly Lum-Naihe; Ryan Toedebusch; Abuzar Mahmood; Jamal Bajwa; Terry Carmack; Senthil A Kumar; Sivakumar Ardhanari; Vincent G DeMarco; Craig A Emter; Lakshmi Pulakat
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

10.  Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair.

Authors:  Yinchuan Xu; Xinyang Hu; Lihan Wang; Zhi Jiang; Xianbao Liu; Hong Yu; Zhaocai Zhang; Huiqiang Chen; Han Chen; Gustav Steinhoff; Jun Li
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.